Merck (MRK) is a publicly traded Healthcare sector company. As of August 9, 2026, MRK trades at $127.95 with a market cap of $317.05B and a P/E ratio of 35.94. MRK moved +0.16% today. Year to date, MRK is +20.79%; over the trailing twelve months it is +59.99%. Its 52-week range spans $73.31 to $135.05. Analyst consensus is buy with an average price target of $136.94. Rallies surfaces MRK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Merck (MRK) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. MRK moved +0.16% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $127.95 |
| Market Cap | $317.05B |
| P/E Ratio | 35.94 |
| EPS | $3.57 |
| Dividend Yield | 0.85% |
| 52-Week High | $135.05 |
| 52-Week Low | $73.31 |
| Volume | 5.08M |
| Avg Volume | 0 |
| Revenue (TTM) | $65.77B |
| Net Income | $8.93B |
| Gross Margin | 73.91% |
18 analysts cover MRK: 0 strong buy, 13 buy, 5 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $136.94.